How pharma can prepare for the future of telehealth

sectionTheme
default
gridBackground
false
id
hero
sectionTheme
default
gridBackground
false
id
share-print

Perhaps it won’t be used at the level we’ve seen during COVID-19, but one thing is certain: Telehealth is here to stay. The question is, how can pharma organizations prepare for and adapt to the future of telehealth? We’ve made two predictions based on market analysis and the findings from several ZS surveys to both inform and assist pharma along the journey.

sectionTheme
default
gridBackground
false
id
text-block-1

sectionTheme
default
gridBackground
false
id
content-block-1

Add insights to your inbox

We’ll send you content you’ll want to read – and put to use.
Sign me up
/content/zs/en/forms/subscription-preferences
sectionTheme
dark
gridBackground
false
id
banner
default

Meet our experts

left
white
Eyebrow Text
Button CTA Text
#
primary
default
sectionTheme
light-grey
gridBackground
false
id
authors
default
tagList
/content/zs/en/insights

/content/zs/en/insights

zs:topic/customer-experience,zs:,zs:topic/research--development

sectionTheme
default
gridBackground
false
id
articles